Literature DB >> 15818101

Ventilator-associated pneumonia: Increased bacterial counts in bronchoalveolar lavage by using urea as an endogenous marker of dilution.

Konstantin Zedtwitz-Liebenstein1, Peter Schenk, Petra Apfalter, Valentin Fuhrmann, Brigitte Stoiser, Wolfgang Graninger, Ernst Schuster, Michael Frass, Heinz Burgmann.   

Abstract

OBJECTIVE: Invasive diagnostic procedures such as bronchoalveolar lavage (BAL) with quantitative microbiological cultures are currently recommended for the diagnosis of nosocomial pneumonia. Commonly, in clinical practice, a threshold of > or =10 colony forming units/mL is used for therapeutic decisions. The use of these measurements in daily practice assumes that their repeatability is acceptable. However, many variations among the positive results have been noted. One of the most important is dilution of BAL, which may influence the quantitative results by minimizing bacterial counts. Knowledge of the extent of dilution may increase dramatically the value of quantitative cultures. The aim of this study was to determine to what extent specimens are diluted in BAL by measuring urea in BAL and blood. Furthermore, the impact of a potential dilution effect on the diagnosis of ventilator-associated pneumonia was studied. PATIENTS AND
SETTING: A total of 47 patients with ventilator-associated pneumonia in two medical intensive care units at the Vienna General Hospital, a university-affiliated facility.
DESIGN: Prospective study performed between January 2001 and July 2002.
METHODS: BAL fluid was divided immediately into two samples: one for direct microscopic examination of cytocentrifuge preparations for Gram staining to determine percentages of cells containing intracellular bacteria and one for quantitative cultures according to the Cumitech 7A guidelines. Epithelial lining fluid volume was calculated using urea as a marker of dilution and correlated with colony forming units per milliliter.
RESULTS: Nineteen out of 47 patients (40%) revealed significant bacterial growth (> or =10 colony forming units/mL). Eight additional patients (17%) would have reached the cutoff level after correction of the dilution effect, which varied between 1.8- and 130-fold.
CONCLUSIONS: Data suggest a great variation of dilution during BAL procedures, which influences quantitative results. Using urea to determine the dilution quotient could increase the value of bacterial thresholds in the diagnosis and therapeutic decision of ventilator-associated pneumonia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15818101     DOI: 10.1097/01.ccm.0000157753.88333.c8

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  7 in total

1.  Biomarkers in the diagnosis of pneumonia in the critically ill: don't shoot the piano player.

Authors:  Santiago Ewig; Tobias Welte
Journal:  Intensive Care Med       Date:  2008-04-08       Impact factor: 17.440

Review 2.  What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review.

Authors:  Chandra Datta Sumi; Aaron J Heffernan; Jeffrey Lipman; Jason A Roberts; Fekade B Sime
Journal:  Clin Pharmacokinet       Date:  2019-11       Impact factor: 6.447

3.  Emergence of Resistance in Klebsiella aerogenes to Piperacillin-Tazobactam and Ceftriaxone.

Authors:  Marco M Custodio; Daniel Sanchez; Beverly Anderson; Keenan L Ryan; Carla Walraven; Renee-Claude Mercier
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

4.  Bacterial ventilator-associated pneumonia: bronchoalveolar lavage results are not influenced by dilution.

Authors:  Olivier Baldesi; Fabrice Michel; Christophe Guervilly; Nathalie Embriaco; Aliocha Granfond; Bernard La Scola; Henri Portugal; Laurent Papazian
Journal:  Intensive Care Med       Date:  2009-02-03       Impact factor: 17.440

5.  Secreted Extracellular Cyclophilin A Is a Novel Mediator of Ventilator-induced Lung Injury.

Authors:  Marissa W Koh; Rhianna F Baldi; Sanooj Soni; Rhodri Handslip; Ying Ying Tan; Kieran P O'Dea; Miroslav Malesevic; Daniel F McAuley; Cecilia M O'Kane; Brijesh V Patel; Masao Takata; Michael R Wilson
Journal:  Am J Respir Crit Care Med       Date:  2021-08-15       Impact factor: 21.405

6.  Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa.

Authors:  T W Felton; J Goodwin; L O'Connor; A Sharp; L Gregson; J Livermore; S J Howard; M N Neely; W W Hope
Journal:  Antimicrob Agents Chemother       Date:  2013-09-03       Impact factor: 5.191

7.  Frequent detection of cytomegalovirus (CMV) DNA in the lower respiratory tract in CMV-seropositive pediatric patients with underlying chronic bronchopulmonary diseases lacking canonical immunosuppression.

Authors:  Amparo Escribano; Marifina Chilet; María Ángeles Clari; Raquel Lucas; Elisa Costa; Dayana Bravo; Beatriz Muñoz-Cobo; Rafael Borrás; David Navarro
Journal:  J Med Virol       Date:  2013-02-13       Impact factor: 2.327

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.